Search research articles
Contact Us
Filters
Showing results (31-40 of 57) with videos related to
Page
of 6
Sort By:
Experimental Hematology
|
February 6, 2013
Homozygosity for killer immunoglobin-like receptor haplotype A predicts complete molecular response to treatment with tyrosine kinase inhibitors in chronic myeloid leukemia patients
Giorgio La Nasa, Giovanni Caocci, Roberto Littera, et al.
Leukemia Research
|
August 26, 2017
HLA-G molecules and clinical outcome in Chronic Myeloid Leukemia
Giovanni Caocci, Marianna Greco, Marcella Arras, et al.
Frontiers in Oncology
|
December 4, 2025
GIMEMA survey on the management of chronic myeloid leukemia patients in the third line and beyond: insights from Italian hematologists
Massimo Breccia, Alfonso Piciocchi, Elisabetta Abruzzese, et al.
Experimental Hematology
|
August 27, 2015
Killer immunoglobulin-like receptors can predict TKI treatment-free remission in chronic myeloid leukemia patients
Giovanni Caocci, Bruno Martino, Marianna Greco, et al.
Journal of Public Health Research
|
May 7, 2021
The association between Major Depressive Disorder and premature death risk in hematologic and solid cancer: a longitudinal cohort study
Federica Sancassiani, Elena Massa, Carla Pibia, et al.
Frontiers in Oncology
|
February 18, 2022
Pro-Inflammatory and Pro-Oxidative Changes During Nilotinib Treatment in CML Patients: Results of a Prospective Multicenter Front-Line TKIs Study (KIARO Study)
Anna Sicuranza, Ilaria Ferrigno, Elisabetta Abruzzese, et al.
Frontiers in Oncology
|
February 11, 2026
The role of satisfaction with care among factors affecting health-related quality of life in people with cancer: a cross-sectional study
Federica Sancassiani, Goce Kalcev, Mirian Agus, et al.
Annals of Hematology
|
May 3, 2019
Incidence and evaluation of predisposition to cardiovascular toxicity in chronic myeloid leukemia patients treated with bosutinib in the real-life practice
Giovanni Caocci, Olga Mulas, Elisabetta Abruzzese, et al.
British Journal of Haematology
|
January 11, 2026
Risk factors and reasons for switching from front-line therapy in the Italian chronic myeloid leukaemia network: A cohort study
Massimo Breccia, Valentina Giai, Tiziana Rosso, et al.
Cell Death & Disease
|
June 30, 2022
Dihydroorotate dehydrogenase inhibition reveals metabolic vulnerability in chronic myeloid leukemia
Mohammad Houshmand, Nicoletta Vitale, Francesca Orso, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 57) with videos related to
Sort By:
Page
of 6
Experimental Hematology
|
February 6, 2013
Homozygosity for killer immunoglobin-like receptor haplotype A predicts complete molecular response to treatment with tyrosine kinase inhibitors in chronic myeloid leukemia patients
Giorgio La Nasa, Giovanni Caocci, Roberto Littera, et al.
Leukemia Research
|
August 26, 2017
HLA-G molecules and clinical outcome in Chronic Myeloid Leukemia
Giovanni Caocci, Marianna Greco, Marcella Arras, et al.
Frontiers in Oncology
|
December 4, 2025
GIMEMA survey on the management of chronic myeloid leukemia patients in the third line and beyond: insights from Italian hematologists
Massimo Breccia, Alfonso Piciocchi, Elisabetta Abruzzese, et al.
Experimental Hematology
|
August 27, 2015
Killer immunoglobulin-like receptors can predict TKI treatment-free remission in chronic myeloid leukemia patients
Giovanni Caocci, Bruno Martino, Marianna Greco, et al.
Journal of Public Health Research
|
May 7, 2021
The association between Major Depressive Disorder and premature death risk in hematologic and solid cancer: a longitudinal cohort study
Federica Sancassiani, Elena Massa, Carla Pibia, et al.
Frontiers in Oncology
|
February 18, 2022
Pro-Inflammatory and Pro-Oxidative Changes During Nilotinib Treatment in CML Patients: Results of a Prospective Multicenter Front-Line TKIs Study (KIARO Study)
Anna Sicuranza, Ilaria Ferrigno, Elisabetta Abruzzese, et al.
Frontiers in Oncology
|
February 11, 2026
The role of satisfaction with care among factors affecting health-related quality of life in people with cancer: a cross-sectional study
Federica Sancassiani, Goce Kalcev, Mirian Agus, et al.
Annals of Hematology
|
May 3, 2019
Incidence and evaluation of predisposition to cardiovascular toxicity in chronic myeloid leukemia patients treated with bosutinib in the real-life practice
Giovanni Caocci, Olga Mulas, Elisabetta Abruzzese, et al.
British Journal of Haematology
|
January 11, 2026
Risk factors and reasons for switching from front-line therapy in the Italian chronic myeloid leukaemia network: A cohort study
Massimo Breccia, Valentina Giai, Tiziana Rosso, et al.
Cell Death & Disease
|
June 30, 2022
Dihydroorotate dehydrogenase inhibition reveals metabolic vulnerability in chronic myeloid leukemia
Mohammad Houshmand, Nicoletta Vitale, Francesca Orso, et al.
Page
of 6